Now in its fifth edition, this meeting is designed to provide participants with a comprehensive overview of cutting-edge research in atherosclerosis, with a particular emphasis on the latest discoveries in immuno-metabolic mechanisms driving disease initiation and progression. Therapies directly targeting immuno-inflammatory pathways in atherosclerotic cardiovascular disease are now closer to clinical application than ever before, underscoring the growing importance of translational perspectives. Building on this momentum, the conference will not only highlight fundamental advances in our understanding of disease biology but also explore their translation into the next generation of transformative therapies for cardiovascular disease.
March 16 2026